Patents by Inventor Felix de la Iglesia

Felix de la Iglesia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled Release Formulations of Opioids
    Publication number: 20110195989
    Abstract: Pharmaceutical formulations containing opioid components that each has a release profile. The components may provide immediate or controlled release of the opioid. The invention is also directed to methods of controlling release of one or more opioid compounds and methods of treating pain.
    Type: Application
    Filed: February 9, 2011
    Publication date: August 11, 2011
    Inventors: Edward M. Rudnic, Michael Vachon, Gary W. Pace, Joseph Berry, Felix de la Iglesia
  • DUAL OPIOID PAIN THERAPY
    Publication number: 20090291975
    Abstract: Provided are pharmaceutical compositions and methods for the alleviation of pain in a patient with optimal ratios of morphine and oxycodone that provide superior analgesic efficacy and lower incidence of adverse side effects compared to morphine and oxycodone alone. The pharmaceutical compositions comprise morphine and oxycodone, or pharmaceutically acceptable salts thereof, in ratios of about 3 to 2 to about 1 to 2, morphine to oxycodone by weight.
    Type: Application
    Filed: May 20, 2009
    Publication date: November 26, 2009
    Inventors: WARREN STERN, Gary W. Pace, Felix A. de la IgLesia, Maree Smith, Patricia Richards
  • Use of enadoline in the treatment of benign prostatic enlargement
    Patent number: 5489607
    Abstract: The instant invention is a method of using known compounds, such as (-)-5.alpha.,7.alpha.,-8.beta.-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4 .5]dec-8-yl]-4-benzofuranacetamide, as agents for treating benign prostatic hyperplasia.
    Type: Grant
    Filed: February 16, 1995
    Date of Patent: February 6, 1996
    Assignee: Warner-Lambert Company
    Inventors: Michael A. Breider, Cynthia L. Courtney, Felix A. De La Iglesia, Alexander W. Gough, Alan L. Metz